Prostate cancer: The androgen receptor remains front and centre

Nat Rev Clin Oncol. 2013 Mar;10(3):126-8. doi: 10.1038/nrclinonc.2013.14. Epub 2013 Feb 5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Abiraterone Acetate
  • Adenocarcinoma / drug therapy*
  • Androgen Antagonists / administration & dosage
  • Androgen Antagonists / pharmacology
  • Androgen Antagonists / therapeutic use*
  • Androgens* / biosynthesis
  • Androstadienes / administration & dosage
  • Androstadienes / pharmacology
  • Androstadienes / therapeutic use*
  • Antineoplastic Agents, Hormonal / administration & dosage
  • Antineoplastic Agents, Hormonal / pharmacology
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Clinical Trials, Phase III as Topic / statistics & numerical data*
  • Disease-Free Survival
  • Docetaxel
  • Enzyme Inhibitors / administration & dosage
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use
  • Humans
  • Male
  • Molecular Targeted Therapy*
  • Multicenter Studies as Topic / statistics & numerical data*
  • Neoplasm Proteins / physiology*
  • Neoplasms, Hormone-Dependent / drug therapy*
  • Prednisone / administration & dosage
  • Prostatic Neoplasms / drug therapy*
  • Randomized Controlled Trials as Topic / statistics & numerical data*
  • Receptors, Androgen / physiology*
  • Steroid 17-alpha-Hydroxylase / antagonists & inhibitors
  • Survival Rate
  • Taxoids / therapeutic use

Substances

  • Androgen Antagonists
  • Androgens
  • Androstadienes
  • Antineoplastic Agents, Hormonal
  • Antineoplastic Agents, Phytogenic
  • Enzyme Inhibitors
  • Neoplasm Proteins
  • Receptors, Androgen
  • Taxoids
  • Docetaxel
  • Steroid 17-alpha-Hydroxylase
  • Abiraterone Acetate
  • Prednisone